Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

FDA clears Google smartwatch tech that calls 911 when a user’s heart stops
Google worked with AI specialists, cardiologists and even stunt performers to develop its new smartwatch feature.
Wearable heart device company to go public, raise up to $155M
Kestra Medical Technologies, known for its wearable heart monitors and defibrillators, intends to sell 10 million common shares priced somewhere between $14 and $16 per share.
FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary
These safety issues have been linked to more than 800 injuries and two deaths. It is possible, the FDA warned, that some patients may require a device to be removed and replaced.
Post-stroke follow-up care considerably worse for women than men
Female stroke survivors are less likely to receive a cardiology referral or undergo cardiac monitoring than their male counterparts.
FDA warns of cybersecurity vulnerabilities in patient monitors
The agency said Contec and Epsimed monitors connected via WiFi are particularly susceptible to cyberattack and could be used to gain access to hospital systems.

Huxley Medical, an Atlanta-based medical device company, has secured U.S. Food and Drug Administration (FDA) clearance for its new Sansa device, a chest-worn patch designed to help diagnose sleep apnea in addition to tracking patient data with electrocardiograms (ECGs) a variety of sensors.

FDA clears chest-worn patch for simultaneous ECG, sleep apnea monitoring

The new device from Huxley Medical offers care teams a way to monitor patients for signs of sleep apnea while also keeping a close eye on their heart health.

Medtronic and Abbott join forces to develop new diabetes tech

Medtronic and Abbott are often seen as rivals in a competitive marketplace, but the two companies are collaborating with a simple goal in mind: improving patient access to high-quality CGM devices.

Abbott’s FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system

Abbott says some FreeStyle Libre 3 sensors need replacement—patients should discontinue use

The new medical device correction only includes a select number of devices. Abbott said they produce inaccurate readings, putting patient health at risk.

FibriCheck, a Belgium-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) for its artificial intelligence-powered digital platform that uses smartphone cameras to obtain heart rhythm measurements.

FDA clears heart rhythm AI that turns smartphones into medical devices

FibriCheck has been increasing its presence in the United States in anticipation of this approval, opening a new office and partnering with U.S. hospitals.

Tech companies team up to help cardiologists reach high-risk heart patients

Guidehealth and Story Health are joining forces to put AI-powered technology in the hands of heart teams.

Thomas Maddox, MD, explains some of the new, innovative technologies people should watch for in cardiology. He said some of these may define how cardiologist practice medicine in the next couple years.

Remote monitoring, AI to play key roles in the future of cardiology

Serious changes could be coming to a cardiology practice near you.

AliveCor, a California-based healthcare company focused on developing on-the-go electrocardiography (ECG) devices, has gained U.S. Food and Drug Administration (FDA) clearance for its KAI 12L artificial intelligence (AI) technology and the new handheld Kardia 12L ECG System.

Dual approvals: AliveCor gains FDA clearance for advanced AI model, handheld ECG system

One of the company's new approvals was for a pocket-sized ECG system designed to be less invasive and easier to use than other devices on the market.

How long do wearable cardiac monitors record data?

Long-term continuous monitoring (LTCM) wearable devices now make up 40% or more of the remote ECG monitoring market due to ease of use and collection of more data.

Remote Monitoring

FDA clears Google smartwatch tech that calls 911 when a user’s heart stops

Wearable heart device company to go public, raise up to $155M

FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary

Post-stroke follow-up care considerably worse for women than men

FDA warns of cybersecurity vulnerabilities in patient monitors